Madison Asset Management, LLC Castle Biosciences Inc Transaction History

Madison Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$16.0 - $45.99 $972,528 - $2.8 Million	-60,783 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$33.17 - $46.98 $4,245 - $6,013	-128 Reduced 0.21%	60,783 $2.73 Million
Q4 2021 Feb 15, 2022	BUY	$39.06 - $67.58 $17,694 - $30,613	453 Added 0.75%	60,911 $2.61 Million
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $660,167 - $851,970	-10,979 Reduced 15.37%	60,458 $4.02 Million
Q2 2021 Aug 09, 2021	BUY	$50.07 - $76.78 $723,811 - $1.11 Million	14,456 Added 25.37%	71,437 $5.24 Million

Q1 2021 May 11, 2021	BUY	$58.92 - $97.33 $2.18 Million - $3.6 Million	36,981 Added 184.91%	56,981 $3.9 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $872,000 - $1.46 Million	20,000 New	20,000 $1.34 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Madison Asset Management, LLC with notifications on news.